Medikit Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3921060004
JPY
2,827.00
327 (13.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Japan Lifeline Co., Ltd.
Jins Holdings, Inc.
Mani, Inc.
Fukuda Denshi Co., Ltd.
Medikit Co., Ltd.
Menicon Co., Ltd.
JEOL Ltd.
PHC Holdings Corp.
Eiken Chemical Co., Ltd.
Hogy Medical Co., Ltd.
Takara Bio, Inc.

Why is Medikit Co., Ltd. ?

1
Poor Management Efficiency with a low ROE of 6.42%
  • The company has been able to generate a Return on Equity (avg) of 6.42% signifying low profitability per unit of shareholders funds
2
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 6.42%
  • Poor long term growth as Net Sales has grown by an annual rate of 4.20% and Operating profit at 3.58% over the last 5 years
  • The company has been able to generate a Return on Equity (avg) of 6.42% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 4.20% and Operating profit at 3.58% over the last 5 years
4
Negative results in Mar 26
  • INTEREST(9M) At JPY 5.76 MM has Grown at inf%
  • ROCE(HY) Lowest at 6.54%
  • DEBT-EQUITY RATIO (HY) Highest at -47.95 %
5
Underperformed the market in the last 1 year
  • The stock has generated a return of 10.69% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 59.79%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Medikit Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Medikit Co., Ltd.
-100.0%
-0.14
15.91%
Japan Nikkei 225
59.79%
2.03
29.50%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
4.20%
EBIT Growth (5y)
3.58%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.51
Sales to Capital Employed (avg)
0.50
Tax Ratio
33.38%
Dividend Payout Ratio
48.46%
Pledged Shares
0
Institutional Holding
0.14%
ROCE (avg)
22.48%
ROE (avg)
6.42%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
0.98
EV to EBIT
5.08
EV to EBITDA
3.54
EV to Capital Employed
0.96
EV to Sales
0.97
PEG Ratio
1.15
Dividend Yield
NA
ROCE (Latest)
18.84%
ROE (Latest)
6.79%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
DEBTORS TURNOVER RATIO(HY)

Highest at 4.68 times

-17What is not working for the Company
INTEREST(9M)

At JPY 5.76 MM has Grown at inf%

ROCE(HY)

Lowest at 6.54%

DEBT-EQUITY RATIO (HY)

Highest at -47.95 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.05 times

INTEREST COVERAGE RATIO(Q)

Lowest at 61,342.96

RAW MATERIAL COST(Y)

Grown by 22.69% (YoY

CASH AND EQV(HY)

Lowest at JPY 44,097.9 MM

OPERATING PROFIT(Q)

Lowest at JPY 1,180.85 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 22.22 %

PRE-TAX PROFIT(Q)

Lowest at JPY 687.34 MM

Here's what is working for Medikit Co., Ltd.

Debtors Turnover Ratio
Highest at 4.68 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Depreciation
Highest at JPY 566.73 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for Medikit Co., Ltd.

Interest
At JPY 5.76 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Interest Coverage Ratio
Lowest at 61,342.96
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio
Highest at -47.95 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 3.05 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Operating Profit
Lowest at JPY 1,180.85 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (JPY MM)

Operating Profit Margin
Lowest at 22.22 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at JPY 687.34 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Cash and Eqv
Lowest at JPY 44,097.9 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost
Grown by 22.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income
Highest at JPY 0.11 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income